I haven't had a chance to read up on psychopharmacology as much as I prefer for a couple years. There are a number of new molecules and a lot of new research.

A couple current points of interest: whether a subgroup of #olanzapine (#Zyprexa) super-responders exists, and whether clinical experience has demonstrated any other drugs to be "drop-in replacements" for olanzapine for any type of patient (mood disorder, psychosis, etc).

If you know of anything, please do tell. #Psychiatry

https://www.justice.gov/opa/pr/eli-lilly-and-company-agrees-pay-1415-billion-resolve-allegations-label-promotion-zyprexa Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-label Promotion of Zyprexa #fda #alzheimer #mdma #pharmaceuticals #zyprexa β€” on the ethics of pharmaceutical companies. This, from 2009.
Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegationsof Off-label Promotion of Zyprexa

American pharmaceutical giant Eli Lilly and Company today agreed to plead guilty and pay $1.415 billion for promoting its drug Zyprexa for uses not approved by the Food and Drug Administration (FDA). This resolution includes a criminal fine of $515 million, the largest ever in a health care case, and the largest criminal fine for an individual corporation ever imposed in a United States criminal prosecution of any kind. Eli Lilly will also pay up to $800 million in a civil settlement with the federal government and the states.